Skip to main content
Clinical Trials/NCT00230555
NCT00230555CompletedPhase 3

The MOM Program at the Children's Hospital of Philadelphia

Children's Hospital of Philadelphia2 sites in 1 country300 target enrollmentStarted: July 2001Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
300
Locations
2
Primary Endpoint
child intelligence, 33 months of age

Study Overview

Brief Summary

The purpose of the MOM Program is to promote child development by helping families become more competent in accessing and using available resources. The program focuses are childhood immunizations, Early Intervention services, lead screening, Early Head Start and Head Start enrollment. The hypothsis is that children receiving the intervention will participate in more of the public services and primary healthcare activities which have been shown to be effective in improving their development.

Detailed Description

The MOM Program is a 3 year randomized controlled trial of mothers and newborns. At enrollment subjects are given a questionnaire to assess self efficacy and a non-verbal test of intelligence. Program personnel are blind to the results of this testing. Test results will be used in data analysis at the end of the study to compare outcomes of the intervention and control groups and to assess how mothers with impaired cognitive ability have benefited from participation in the study.The Intervention consists of frequent phone calls and home visits to encourage mothers to have their babies immunized on schedule and to participate in needed developmental and educational services. At 33 months of age all children receive a developmental assessment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
1 Day to 3 Days (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • mothers from West and South Philadelphia who have given birth on the post-partum unit at the Hospital of the University of Pennsylvania during the six month enrollment period from July, 2001 to Jan, 2002..

Exclusion Criteria

  • women or infants who are critically ill, those involving multiple births (ie twins), and women who are solely non-English speaking.

Outcomes

Primary Outcomes

child intelligence, 33 months of age

Secondary Outcomes

  • At child age 33 months: maternal intelligence
  • At child age 33 months:caregiver depression
  • At child age 33 months: childhood immunization completion At child age 33 months: Early Intervention usage

Investigators

Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

The MOM Program at the Children's Hospital... | Clinical Trial